Webinar

Translating In Vitro and In Vivo Multi-Omics Oncology Data to Enhance Early Biomarker Discovery

Thursday, December 12, 2024 | 11:00 AM EST, 8:00 AM PST, 5:00 PM CET

Discover how multi-omics data can drive early biomarker discovery in oncology drug development

This webinar explores the importance of early biomarker identification for reducing risks and increasing clinical success. Dr. Rajendra Kumari will share insights on using oncology models—from cell lines to organoids and patient-derived xenografts (PDX)—to advance precision medicine, address drug resistance, and refine combination therapies.

Learn how multi-omics data and in silico techniques turn complex datasets into impactful biomarkers, helping you make informed, patient-centered decisions for the best outcome in personalized therapy. Don’t miss this chance to stay ahead in oncology drug development and biomarker discovery.

Register Now

Key Takeaways:

• Integrate multi-omics data from diverse oncology models to identify early biomarkers and reduce drug development risks.
• Translate complex in vitro and in vivo data into actionable clinical insights.
• Discover optimal approaches for using advanced models like organoids and PDX in precision medicine.
• Leverage in silico expertise to enhance biomarker discovery and guide clinical trial strategies.

Register Now

About the speaker:

Rajendra Kumari, PhD, Executive Director, Integrated Solutions, Crown Bioscience

As Executive Director of Integrated Solutions within the Commercial and Strategic Development team, Rajendra leads the focus of cross-disciplinary solutions for drug discovery and development. She has over 20 years of oncology research experience with a Ph.D. in Molecular Pharmacology from the University of Leicester (UK). Prior to joining Crown Bioscience, Rajendra held post-doctoral fellowships and an Assistant Professor position in the Division of Preclinical Oncology within the Medical School, University of Nottingham, where she developed in vitro and in vivo preclinical models, including patient-derived systems and imaging capabilities. Rajendra also co-founded PRECOS Ltd. in 2010, serving as COO and then following the merger with Crown Bioscience, as CSO and General Manager for Crown Bioscience UK. In 2018, Rajendra became the Global Head of Scientific Communications for all platforms at Crown Bioscience Inc., working closely with multiple divisions and global departments to support the commercialization of R&D activity and capabilities. Rajendra is a member of the AACR and BACR and has authored over 40 abstracts and publications.